P2.13-11 EGFR Amplification and Sensitizing Mutations Correlates With Survival From Erlotinib in Lung Adenocarcinoma Patients (MutP-CLICAP¶)
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1406
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV